DNAJC7
Basic information
Region (hg38): 17:41976421-42021376
Previous symbols: [ "TTC2" ]
Links
Phenotypes
GenCC
Source:
- amyotrophic lateral sclerosis (Limited), mode of inheritance: AD
- amyotrophic lateral sclerosis (Limited), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DNAJC7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 16 | 16 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 9 | |||||
Total | 0 | 0 | 17 | 1 | 10 |
Variants in DNAJC7
This is a list of pathogenic ClinVar variants found in the DNAJC7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-41976759-C-G | not specified | Uncertain significance (Aug 11, 2024) | ||
17-41977224-T-G | Benign (May 12, 2021) | |||
17-41977285-C-T | not specified | Uncertain significance (Feb 14, 2024) | ||
17-41982377-G-A | Epilepsy;Neurodevelopmental delay | Uncertain significance (Nov 20, 2017) | ||
17-41983568-G-C | not specified | Uncertain significance (Sep 26, 2024) | ||
17-41983601-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
17-41987883-C-A | not specified | Uncertain significance (Nov 03, 2022) | ||
17-41988760-T-A | not specified | Uncertain significance (Oct 06, 2022) | ||
17-41988782-T-C | not specified | Uncertain significance (Jun 29, 2023) | ||
17-41989457-C-T | not specified | Uncertain significance (Jul 15, 2021) | ||
17-41989516-T-G | DNAJC7-related condition | Uncertain significance (Sep 18, 2024) | ||
17-41989531-T-C | not specified | Uncertain significance (Dec 07, 2024) | ||
17-41990103-C-T | Benign (May 11, 2021) | |||
17-41990222-TG-T | Benign (May 11, 2021) | |||
17-41990284-T-C | Benign (May 04, 2021) | |||
17-41990351-A-T | not specified | Uncertain significance (Jul 17, 2023) | ||
17-41990364-G-A | not specified | Uncertain significance (Feb 14, 2023) | ||
17-41994886-T-C | not specified | Uncertain significance (Feb 22, 2023) | ||
17-41994898-G-C | not specified | Uncertain significance (Apr 27, 2022) | ||
17-41994929-C-T | not specified | Uncertain significance (Apr 08, 2022) | ||
17-41994952-G-A | Benign (May 04, 2021) | |||
17-41996329-A-G | Likely benign (May 01, 2022) | |||
17-41996366-C-T | not specified | Uncertain significance (Feb 10, 2022) | ||
17-41997144-A-C | not specified | Uncertain significance (Dec 09, 2023) | ||
17-41997236-A-G | Amyotrophic lateral sclerosis | Uncertain significance (Sep 09, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
DNAJC7 | protein_coding | protein_coding | ENST00000457167 | 14 | 44944 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.990 | 0.00993 | 124634 | 0 | 7 | 124641 | 0.0000281 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.51 | 158 | 275 | 0.574 | 0.0000145 | 3281 |
Missense in Polyphen | 20 | 60.921 | 0.32829 | 712 | ||
Synonymous | -0.327 | 100 | 95.9 | 1.04 | 0.00000490 | 860 |
Loss of Function | 4.54 | 4 | 31.5 | 0.127 | 0.00000187 | 362 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000559 | 0.0000556 |
Finnish | 0.0000476 | 0.0000464 |
European (Non-Finnish) | 0.0000360 | 0.0000354 |
Middle Eastern | 0.0000559 | 0.0000556 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as co-chaperone regulating the molecular chaperones HSP70 and HSP90 in folding of steroid receptors, such as the glucocorticoid receptor and the progesterone receptor. Proposed to act as a recycling chaperone by facilitating the return of chaperone substrates to early stages of chaperoning if further folding is required. In vitro, induces ATP-independent dissociation of HSP90 but not of HSP70 from the chaperone- substrate complexes. Recruits NR1I3 to the cytoplasm (By similarity). {ECO:0000250, ECO:0000269|PubMed:12853476, ECO:0000269|PubMed:18620420}.;
- Pathway
- Constitutive Androstane Receptor Pathway;Pregnane X Receptor pathway;Nuclear Receptors Meta-Pathway;Regulation of HSF1-mediated heat shock response;Cellular responses to stress;Cellular responses to external stimuli;Cellular response to heat stress
(Consensus)
Recessive Scores
- pRec
- 0.244
Intolerance Scores
- loftool
- rvis_EVS
- -0.43
- rvis_percentile_EVS
- 25.15
Haploinsufficiency Scores
- pHI
- 0.466
- hipred
- Y
- hipred_score
- 0.662
- ghis
- 0.662
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.907
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dnajc7
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); liver/biliary system phenotype; growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- protein folding;positive regulation of ATPase activity;chaperone cofactor-dependent protein refolding;regulation of cellular response to heat
- Cellular component
- nucleoplasm;cytoplasm;cytosol;cytoskeleton;membrane;extracellular exosome
- Molecular function
- ATPase activator activity;protein binding;heat shock protein binding